1Royal Free Hospital School of Medicine, University of London, UK.
Tacrolimus (FK506) is a novel immunosuppressant that inhibits T-lymphocyte responses by blocking interleukin 2 transcription. Clinical trials show it is comparable to cyclosporin in efficacy and toxicity.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: